Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 17,119 shares at $23.81 ($408K) on 2025-01-15, disclosed to the SEC on 2025-01-17.
Seasonal sale ($408k) by Chief Executive Officer — this insider has traded IMVT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.81 | 8,352 | $199K | 48.8% |
| 2 | $23.81 | 8,352 | $199K | 48.8% |
| 3 | $24.19 | 415 | $10K | 2.5% |
| Total | $23.82 avg | 17,119 | $408K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $644K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |
| IMVT | SELL | 2024-11-22 | $850K | — | Filing → |